May 4, 2021BioVaxys, BioElpida Collaborate to Produce Ovarian Cancer VaccineBioVaxys is also developing vaccines against ovarian cancer and the SARS-CoV-2 virus.
May 4, 2021MoonLake Immunotherapeutics Licenses Skin and Joint Treatment from Merck KGaAMoonlake is planning multiple phase 2 trials.
May 4, 2021Esteve Signs U.S. Licensing Deal with Kowa Pharmaceuticals for Acute Pain DrugEsteve will supply the drug and will retain global rights, except in the U.S. and Canada.
April 27, 2021Canada’s 1.5 Million AstraZeneca Doses From Troubled Emergent Plant Safe and High Quality, Regulator Says
